Las Vegas Sands chairman Sheldon Adelson is taking medical leave for cancer treatment, the second such break since his 2019 diagnosis of non-Hodgkin’s lymphoma. 

On Thursday, Sands announced that Adelson would be taking a medical leave of absence as he resumes his cancer treatment. Sands president/COO Rob Goldstein has been named acting CEO/chairman of Sands and Sands China during the 87-year-old Adelson’s absence.  

It’s unclear how long Adelson’s treatment will take. His cancer diagnosis became public knowledge in the spring of 2019 and Adelson didn’t return to active duty until October of that year. Adelson also suffers from peripheral neuropathy, a condition that often leaves him reliant on an electronic scooter to get around. 

Investors initially took the news hard, pushing Sands’ share price down around 1.5% by mid-morning, but the shares have since rebounded and are currently sitting close to where they started the day. Deutsche Bank analysts issued a note suggesting Goldstein was “more than simply well equipped” to hold the fort until Adelson’s return.